PCSK9 in vascular smooth muscle cells: biology, pathology, and inhibition to fight atherosclerosis
Atherosclerosis remains the principal cause of cardiovascular morbidity and mortality worldwide, with vascular smooth muscle cells (VSMC) serving as central effectors in plaque initiation, progression, and destabilization. Although originally characterized as a hepatic regulator of LDL receptor degr...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2026-06-01
|
| Edice: | Atherosclerosis Plus |
| Témata: | |
| On-line přístup: | http://www.sciencedirect.com/science/article/pii/S2667089525000549 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|